发明名称 |
TARGETED ALPHA PARTICLE THERAPY USING ACTINIUM-225 CONJUGATES |
摘要 |
The present invention provides functionalized chelants and a method of treating cancerous cells with alpha particles comprising the step of administering a pharmacologically effective dose of an 225Ac conjugate comprising a functionalized chelant R is independently CHQCO2X; Q is independently hydrogen; C1-C4 alkyl or (C1-C2 alkyl) phenyl; X is independently hydrogen; benzyl or C1-C4 alkyl; Z1 is (CH2)nY where n is 1-10 and Y is an electrophilic or nucleophilic moiety and Z2 is R; or, alternatively, Z1 is hydrogen and Z2 is a peptide linker composed of 1-10 amino acids; said Y or said peptide linker covalently attached to an antibod y or fragment thereof, or other biologic molecule; or a pharmaceutically acceptable salt thereof, complexed with 225Ac. These biologic molecule binds to cancerous cells and 225Ac or its daughters emit alpha particles into said cancerous cells effecting treatment. |
申请公布号 |
EP1317268(A2) |
申请公布日期 |
2003.06.11 |
申请号 |
EP20010979247 |
申请日期 |
2001.09.14 |
申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
发明人 |
SCHEINBERG, DAVID;MA, DANGSHE;MCDEVITT, MICHAEL;BORCHARDT, PAUL |
分类号 |
A61K51/10;(IPC1-7):A61K51/08 |
主分类号 |
A61K51/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|